Latest News

Apollo Commercial Real Estate Finance (NYSE:ARI) was removed from over a dozen major Russell indices in a single day. The cuts followed its recent removal from key S&P indices. The changes occur while ARI is in an ongoing liquidation process. Apollo Commercial Real Estate Finance is a commercial mortgage real estate investment trust, so index inclusion has been an important channel for passive capital and trading volume. Being dropped from a broad set of Russell indices after earlier S&P...

CMS Energy (CMS) is back on investors’ radar after recent trading left the stock roughly flat over the past month but lower over the past 3 months, inviting closer attention to its fundamentals. See our latest analysis for CMS Energy. At around $73.65, CMS Energy’s recent share price softness, including a 1-day decline of about 1% and a 7-day drop of roughly 2%, contrasts with a positive year to date share price return of 4.6% and multi year total shareholder returns between 5.5% and 38.4%...

Recent commentary on Procore Technologies (PCOR) has focused on slowing annual recurring revenue growth and continued operating losses, which have contributed to weaker sentiment around the stock and questions about its cost base. See our latest analysis for Procore Technologies. Despite the recent concerns, Procore Technologies’ share price has shown a short-term rebound, with a 1-month share price return of 14.90% and a 7-day share price return of 6.05%. However, momentum has eased over a...

Right leaning politics are moving closer to the mainstream in Britain, and that shift is already shaping expectations around regulation, taxation, and cross border ties with the US. For investors, the key question is which stocks are directly exposed to this changing political mood, and how that exposure could help or hurt future returns. This article looks at three UK listed stocks that sit squarely in the path of these policy trends. It explains why the recent news matters for their...

Himax Technologies (HIMX) has drawn investor attention after a recent stretch of mixed share performance, with the stock down about 29% over the past month but up roughly 16% in the past 3 months. See our latest analysis for Himax Technologies. At a share price of $12.80, Himax Technologies has seen short term momentum fade with the 7 day share price return down 15.96% and the 30 day share price return down 29.32%. This comes even as the year to date share price return of 50.06% and 3 year...

Tryg (CPSE:TRYG) has drawn investor attention after updating its 2026 and 2027 revenue guidance, reporting lower second quarter earnings, and affirming a DKK 2.15 ordinary dividend for the period. See our latest analysis for Tryg. At a share price of DKK155.4, Tryg has seen a 3.39% 1 month share price return but is down 5.88% year to date, while its 1 year total shareholder return is 2.72% and 3 year total shareholder return is 34.31%. This suggests that shorter term momentum has faded even...

Caledonia Mining stock has given shareholders a 76.5% return over the past 5 years, yet its current share price of US$16.98 still screens as cheap when lined up against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and traditional market multiples. Over 5 years, a 76.5% total return suggests Caledonia Mining has already rewarded patient investors, so the key issue now is whether the current price still offers a margin between value and expectations. Future cash flow...

Darden Restaurants (DRI) is back in focus after Olive Garden revived its never ending pasta promotion and Pasta Pass, a value driven offer aimed at drawing budget conscious diners and supporting traffic. See our latest analysis for Darden Restaurants. The pasta promotion comes as Darden Restaurants’ share price has eased in the short term, with a 1-month share price return of 6.99% and a 7-day share price return of 2.80% both declining. In contrast, the 3-year total shareholder return of...

Earlier this month, Allergan Aesthetics, an AbbVie company, received European Commission approval for Boey (trenibotulinumtoxinE), the first rapid-onset, short-duration botulinum neurotoxin serotype E for temporarily improving moderate to severe glabellar lines across all 30 European Economic Area countries. By offering quicker visible results and a shorter treatment effect window than traditional neurotoxins, Boey introduces a differentiated option that could broaden AbbVie’s appeal to...

Steris recently entered the spotlight as investors reacted to expectations around its now-past fiscal first-quarter 2027 earnings release, with analysts having projected a 7.7% increase in profit per share versus the prior year and pointing to a solid record of meeting or beating estimates. What stands out is how this anticipated profit improvement, combined with Steris’s track record in recent quarters, appears to be shaping confidence in the company’s ability to sustain its earnings...

Arcutis Biotherapeutics recently announced that the FDA accepted its supplemental New Drug Application for ZORYVE (roflumilast) cream 0.05% to extend its approved use in mild to moderate atopic dermatitis to infants aged 3 to 24 months, supported by positive Phase 1 and Phase 2 infant studies. This move highlights how Arcutis is working to broaden ZORYVE’s reach into younger pediatric populations, deepening its presence in non-steroidal dermatology treatments across multiple age groups and...

Uniper stock reacts to €5 billion investment and potential government exit Uniper (XTRA:UN0) is back in focus after outlining about €5 billion in planned investment from 2025 to 2030 and flagging the potential sale of the German government’s majority stake. See our latest analysis for Uniper. The €5 billion investment plan and the prospect of a government exit come after a mixed period for Uniper, with the share price delivering a 28.34% year to date return but a 3 year total shareholder...

McKesson (MCK) is back in focus as investors react to upbeat analyst sentiment ahead of its second quarter earnings, with forecasts calling for strong profit growth and closer scrutiny of the company’s guidance. See our latest analysis for McKesson. At a share price of $841.39, McKesson has seen a 12.09% 1 month share price return and a 19.02% 1 year total shareholder return, indicating that recent momentum aligns with longer term compounding. If the setup around McKesson has you thinking...

Wintrust Financial Corporation recently agreed to acquire Northern Trust’s guardianship services operations and is expected to report higher Q2 earnings than a year earlier. This combination of anticipated earnings strength and a targeted expansion into specialized fiduciary services could reshape how investors view Wintrust’s long-term business mix. Next, we will examine how the guardianship services acquisition influences Wintrust’s investment narrative and broader growth prospects for...

Why a recent upgrade is putting Palo Alto Networks in focus Capital One’s upgrade of Palo Alto Networks (PANW), tied to its platformization efforts and AI focused security products, has pushed the stock into the spotlight as investors reassess its recurring revenue profile. See our latest analysis for Palo Alto Networks. The upgrade comes alongside strong price momentum, with Palo Alto Networks’ share price at $358.68 and a 30 day share price return of 24.64%. Its 1 year and 5 year total...

Earlier this week, reports surfaced that OpenAI is developing a mobile, screen-free smart speaker for consumers, marking its first major move into dedicated hardware and intensifying competition in the smart home audio space. The development highlights how Sonos’s efforts to turn its large base of connected speakers into an AI-enabled platform could be tested by a powerful new entrant focused on similar capabilities. We’ll now examine how rising AI-focused competition in smart speakers could...

LPL Financial Holdings (LPLA) is in focus after HighWater Wealth, a multi family office team reporting about $2.4b in advisory assets, joined its broker dealer and RIA platform from U.S. Bank. See our latest analysis for LPL Financial Holdings. At a share price of $324.9, LPL Financial Holdings has seen a 10.53% 1 month share price return and a decline of 10.16% year to date, while its 5 year total shareholder return of 139.33% points to stronger longer term momentum. If this kind of advisor...

Bonheur ASA has reported its second-quarter 2026 results, with sales of NOK 3,035 million and net income of NOK 302 million, both lower than the same period last year. The sharp reduction in basic earnings per share from continuing operations to NOK 7.1 from NOK 20.6 highlights a much weaker profit contribution in the period. We’ll now examine how this weaker second-quarter profitability, particularly the drop in net income, may influence Bonheur’s existing investment narrative. Invest in...

With inflation trends looking mixed, bond yields adjusting and energy shocks keeping nerves on edge, many investors are again paying attention to steady income rather than quick gains. That is where the Dividend Powerhouses screener comes in. It focuses on companies offering more than a 5% dividend yield that is described as well covered, growing and stable. For anyone trying to build a more reliable cash flow from equities, this kind of discipline can help filter out potential traps. In this...

Corporación América Airports reported that total passenger traffic fell 4.1% year-on-year in June 2026, with domestic volumes hurt by weaker demand in Argentina and the temporary impact of the FIFA World Cup on travel patterns. Despite the overall decline, international passenger traffic actually grew across most of the group’s markets, highlighting how Argentina’s softness disproportionately weighed on consolidated results. We’ll now examine how June’s Argentina-driven passenger decline,...

Israel’s recent market swings, with Tel Aviv indices under pressure, a weaker shekel and pockets of strength in bank and energy stocks, have created a very specific kind of stock picker’s market. Currency moves and sector splits are exposing which companies are simply following the market and which are directly tied to these catalysts. This article focuses on three stocks from the Israeli Bank and Energy Stocks With Currency Tailwinds screener that appear positively exposed to the latest...

Chevron (CVX) has signed preliminary agreements with Iraq to enter the West Qurna 2 and Nasiriyah oilfields and study new export pipelines that bypass the Strait of Hormuz, potentially reshaping its Middle East exposure. See our latest analysis for Chevron. These Iraq agreements come as Chevron stock builds momentum, with a 7.9% 1 month share price return and 20.2% year to date share price return, while the 5 year total shareholder return of 132.7% points to strong long run compounding. If...

Merck stock has delivered a strong 92.2% return over the past 5 years, yet its current valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares may sit below what the underlying cash flows imply while market multiples look closer to fair. A 92.2% gain over 5 years puts Merck among the stronger large pharma performers, which raises the question of how much of its pipeline and cash flow potential is already reflected in the price. Recent...

Broadcom (AVGO) has been caught in a sharp semiconductor sell-off after Chinese startup Moonshot unveiled its Kimi K3 open-source AI model, raising questions about US AI leadership and weighing on chip stocks. See our latest analysis for Broadcom. Broadcom’s recent slide, including a 7.3% decline in the 7-day share price return and a 9.9% drop over 30 days, comes after a strong run. The year-to-date share price return remains positive at 6.7% and the 1-year total shareholder return is 31.8%...